IRIS
LAGHI PASINI, FRANCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.949
EU - Europa 8.070
AS - Asia 1.629
SA - Sud America 68
AF - Africa 45
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 11
AN - Antartide 1
Totale 19.788
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.909
GB - Regno Unito 2.395
IE - Irlanda 1.380
CN - Cina 1.079
SE - Svezia 831
UA - Ucraina 807
IT - Italia 671
DE - Germania 595
RU - Federazione Russa 563
FR - Francia 417
SG - Singapore 293
FI - Finlandia 234
VN - Vietnam 112
BR - Brasile 52
ES - Italia 47
IN - India 41
BE - Belgio 38
CI - Costa d'Avorio 34
CA - Canada 32
TR - Turchia 28
NL - Olanda 22
TH - Thailandia 18
CZ - Repubblica Ceca 17
AU - Australia 12
GR - Grecia 12
EU - Europa 11
JP - Giappone 7
LT - Lituania 6
MA - Marocco 6
HK - Hong Kong 5
IL - Israele 5
IR - Iran 5
PL - Polonia 5
AR - Argentina 4
HR - Croazia 4
ID - Indonesia 4
KZ - Kazakistan 4
MX - Messico 4
AZ - Azerbaigian 3
BG - Bulgaria 3
EC - Ecuador 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
PE - Perù 3
PK - Pakistan 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AT - Austria 2
CL - Cile 2
CO - Colombia 2
CY - Cipro 2
JO - Giordania 2
KG - Kirghizistan 2
PA - Panama 2
RS - Serbia 2
UZ - Uzbekistan 2
BO - Bolivia 1
CH - Svizzera 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
FK - Isole Falkland (Malvinas) 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HU - Ungheria 1
IM - Isola di Man 1
IQ - Iraq 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
MY - Malesia 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
PH - Filippine 1
PT - Portogallo 1
SA - Arabia Saudita 1
SM - San Marino 1
SY - Repubblica araba siriana 1
Totale 19.788
Salva come PNG Salva come JPEG
Città #
Southend 2.233
Fairfield 1.488
Dublin 1.351
Ashburn 804
Chandler 734
Woodbridge 691
Jacksonville 642
Wilmington 574
Menlo Park 539
Santa Clara 530
Seattle 525
Houston 515
Cambridge 470
Ann Arbor 397
Siena 316
Princeton 266
Beijing 248
Nanjing 232
Singapore 186
Boardman 117
Dearborn 113
Dong Ket 111
Helsinki 106
New York 96
San Diego 96
San Mateo 92
Nanchang 84
Moscow 62
Shenyang 57
Shanghai 56
Málaga 46
Florence 43
Tianjin 41
Hebei 40
Venezia 39
Brussels 38
Kunming 37
Abidjan 34
Düsseldorf 31
Jiaxing 31
Lancaster 29
Jinan 27
Changsha 26
San Francisco 25
Izmir 24
Norwalk 24
Falls Church 21
London 21
Toronto 20
Guangzhou 19
Hefei 18
Washington 18
Lappeenranta 16
Mestre 16
Munich 16
Redwood City 16
Ningbo 15
Zhengzhou 15
Los Angeles 14
Rome 13
Chicago 12
Pune 12
Hangzhou 11
Brno 10
Changchun 10
Fremont 10
Lanzhou 10
Ottawa 10
Caserta 9
Paris 9
Taizhou 9
São Paulo 8
Tappahannock 8
Dallas 7
Delhi 7
Fuzhou 7
Milan 7
Philadelphia 7
Pisa 7
Hounslow 6
Hyderabad 6
Olomouc 6
Phoenix 6
Sacramento 6
Wuhan 6
Amsterdam 5
Auburn Hills 5
Canberra 5
Frankfurt am Main 5
Petah Tikva 5
Prato 5
Renton 5
Rufina 5
Athens 4
Bari 4
Clifton 4
Hong Kong 4
Modena 4
Newark 4
Saint Petersburg 4
Totale 14.778
Salva come PNG Salva come JPEG
Nome #
Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes 291
Searching Novel Therapeutic Targets for Scleroderma: P2X7-Receptor Is Up-regulated and Promotes a Fibrogenic Phenotype in Systemic Sclerosis Fibroblasts 275
Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis 256
Arrhythmogenicity of Anti-Ro/SSA antibodies in patients with torsades de pointes 242
Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system 237
Proton pump inhibitors and serum magnesium levels in patients with Torsades de Pointes 236
Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. 224
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α 217
Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2 217
Antiarrhythmic potential of anti-cytokine therapy in rheumatoid arthritis: Tocilizumab reduces QTc interval by controlling systemic inflammation. 217
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 216
Non-HCV-related cryoglobulinemic vasculitis and parvovirus-B19 infection 209
Torsades de Pointes in patients with polymyalgia rheumatica 204
Spotlight on sirukumab for the treatment of rheumatoid arthritis: The evidence to date 198
Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults 197
Adenosine receptors expression in cardiac fibroblasts of patients with left ventricular dysfunction due to valvular disease 190
Statins and the joint: multiple targets for a global protection? 189
Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis 187
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 186
Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin-6–Mediated Changes in Connexin Expression 184
Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity 181
QTc interval prolongation during infusion with dipyridamole or adenosine 176
Induction of autoimmune response to the extracellular loop of the HERG channel pore induces QTc prolongation in guinea-pigs 175
Typical and severe tumor necrosis factor receptor-associated periodic syndrome in the absence of mutations in the TNFRSF1A gene: a case series 174
Generalised reduction of putative endothelial progenitors and CXCR4-positive peripheral blood cells in type 2 diabetes. 171
Isolated atrioventricular block of unknown origin in the adult and autoimmunity: Diagnostic and therapeutic considerations exemplified by 3 anti-Ro/SSA-associated cases 169
Connective tissue diseases and cardiac rhythm disorders: an overview 164
Assessing QT interval in patients with autoimmune chronic inflammatory diseases: perils and pitfalls 164
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 159
Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA positive connective tissue diseases 158
The role of P2X7 receptors in tissue fibrosis: a brief review 157
Cyclosporin and tacrolimus increase plasma levels of adenosine in kidney transplanted patients 155
Autoimmune and inflammatory K+ channelopathies in cardiac arrhythmias: Clinical evidence and molecular mechanisms 155
Simvastatin inhibits T cell activation by selectively impairing the function of RAS superfamily GTPases 154
Early and delayed increase in plasma homocysteine levels in heart transplanted patients. 153
Isolated atrioventricular block of unknown origin in adults and anti-Ro/SSA antibodies: Clinical evidence, putative mechanisms, and therapeutic implications 153
T lymphocytes as targets of statins: molecular mechanisms and therapeutic perspectives 151
Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells. 151
Pravastatin treatment-associated reduction in plasma homocysteine in heart-transplanted patients. 150
Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation 150
Heart failure and chronic kidney disease in a registry of internal medicine wards 150
Simvastatin impairs humoral and cell-mediated immunity in mice by inhibiting lymphocyte homing, T-cell activation and antigen cross-presentation. 150
Pharmacokinetics and pharmacodynamics of neutrophil-associated ciprofloxacin in humans 149
Cytokine production from peripheral mononuclear cells in 2 patients affected by adrenomyeloneuropathy 149
Effects of fluoxetine treatment on carbohydrate metabolism in human blood platelets: a 1H-NMR study 148
Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications 147
Comparison of disease clusters in two elderly populations hospitalized in 2008 and 2010 147
Modulation of P2X7 receptor during inflammation in multiple sclerosis 147
Chronic protection against ischemia and reperfusion-induced endothelial dysfunction during therapy with different organic nitrates 146
Correlation between cardiac oxidative stress and myocardial pathology due to acute and chronic norepinephrine administration in rats 146
Role of etanercept in the treatment of tumor necrosis factor receptor-associated periodic syndrome: personal experience and review of the literature 146
null 145
Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. 144
The "Invulnerability" of the Adult Conduction System to Anti-Ro/SSA Antibodies? A Matter of Calcium Channel Expression on the Cardiomyocyte 144
Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias 144
Using peripheral blood mononuclear cells to determine proteome profiles in human cardiac failure 143
Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis 143
Evidence of an adenosine-dependent mechanism in the hypotensive effect of L-arginine in man 142
Inflammatory cytokines, life-threatening arrhythmias and premature mortality in chronic inflammatory arthritis: Time to focus on 142
Development and preliminary validation of a diagnostic score for identifying patients affected with adult-onset autoinflammatory disorders 142
One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies 141
Biologic drugs and arrhythmic risk in chronic inflammatory arthritis: the good and the bad 141
Simvastatin inhibits the MHC class II pathway of antigen presentation by impairing Ras superfamily GTPases. 140
The effects of age and hyperhomocysteinemia on the redox forms of plasma thiols 139
Acute effects of glibenclamide on reactive hyperaemia in the lower limbs in humans. 138
Opposite effects of simvastatin on the bactericidal and inflammatory response of macrophages to opsonized S. aureus 137
Autoimmune Calcium Channelopathies and Cardiac Electrical Abnormalities 137
Peripheral neuropathy associated with ischemic vascular disease of the lower limbs 136
Reduction in plasma homocysteine level in patients with rheumatoid arthritis given pulsed glucocorticoid treatment. 135
Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome 134
Cardiac dysautonomia in patients with superior vena cava syndrome due to compression by lung cancer. 133
A Heterologous MF59-Adjuvanted H5N1 Prepandemic Influenza Booster Vaccine Induces a Robust, Cross-Reactive Immune Response in Adults and the Elderly. 133
Anti-Ro/SSA antibodies and cardiac arrhythmias in the adult: facts and hypotheses 133
Homocysteine and Raynaud’s phenomenon: a review 133
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 131
Severe acute graft versus host disease after lung transplant: report of a case successfully treated with high dose corticosteroids 131
Psychosine-induced apoptosis and cytokine activation in immune peripheral cells of Krabbe patients. 130
Familial Mediterranean fever diagnosed in an elderly patient 128
Human rheumatoid synoviocytes express functional P2X7 receptors 128
Extracorporeal photopheresis affects interleukin (IL)-10 and IL-12 production by monocytes in patients with chronic graft-versus-host disease 128
Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts 126
null 126
Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies 124
Pathogenesis of the novel autoimmune-associated long-QT syndrome 123
Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome, and Torsades de Pointes Risk 123
Arrhythmic risk during acute infusion of infliximab: a prospective, single-blind, placebo-controlled, cross-over study in patients with chronic arthritis 122
Statins as a new therapeutic perspective in myocarditis and postmyocarditis dilated cardiomyopathy 122
null 122
null 122
Priming for Pandemic Influenza: Antigen-sparing MF59™-adjuvanted A/H5N1 Vaccine Induces Immunological Memory and Shows Cross-Reactive Potential in Adults Including the Elderly 121
Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation 121
Sacroileitis and pericarditis: atypical presentation of tumor necrosis factor receptor-associated periodic syndrome and response to etanercept therapy. 120
Corrected QT interval in anti-SSA-positive adults with connective tissue disease: Comment on the article by Lazzerini et al. [6] (multiple letters) 120
Adenosine A2(A) receptor gene polymorphism (1976C > T) affects coronary flow reserve response during vasodilator stress testing in patients with non ischemic-dilated cardiomyopathy 119
Comment on: Letter to the Editor from Clockaerts and Bierma-Zeinstra 119
Potassium Channel Block and Novel Autoimmune-Associated Long QT Syndrome 119
Emerging arrhythmic risk of autoimmune and inflammatory cardiac channelopathies 119
Oral low-dose dipyridamole protects from intravenous high-dose dipyridamole-induced ischemia. A oral echocardiographic study 117
Tumour necrosis factor receptor-associated periodic syndrome caused by a rare mutation in the TNFRSF1A gene, and with excellent response to etanercept treatment. 117
Haemodynamics, rheology and mechanism of action of iloprost in man 115
Totale 15.609
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.897
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.897
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.350 0 0 0 0 0 372 425 526 331 351 122 223
2020/20212.825 141 306 93 284 146 348 111 375 287 262 230 242
2021/20222.075 147 273 129 173 135 58 103 105 113 180 206 453
2022/20232.706 168 243 394 385 245 546 70 191 289 64 61 50
2023/20242.205 98 31 168 103 103 632 720 57 22 51 55 165
2024/20251.625 74 207 350 248 514 232 0 0 0 0 0 0
Totale 20.060